Packaged Foods
Compare Stocks
5 / 10Stock Comparison
BRBR vs HIMS vs TDOC vs SMPL vs NOMD
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Equipment & Services
Medical - Healthcare Information Services
Packaged Foods
Packaged Foods
BRBR vs HIMS vs TDOC vs SMPL vs NOMD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Packaged Foods | Medical - Equipment & Services | Medical - Healthcare Information Services | Packaged Foods | Packaged Foods |
| Market Cap | $1.20B | $7.30B | $1.31B | $1.22B | $1.34B |
| Revenue (TTM) | $2.33B | $2.35B | $2.51B | $1.45B | $3.00B |
| Net Income (TTM) | $81M | $128M | $-171M | $91M | $133M |
| Gross Margin | 30.2% | 69.7% | 65.6% | 34.0% | 26.6% |
| Operating Margin | 12.6% | 4.6% | -7.6% | 14.4% | 10.6% |
| Forward P/E | 7.7x | 58.3x | — | 7.4x | 6.2x |
| Total Debt | $1.11B | $1.12B | $1.04B | $304M | $2.29B |
| Cash & Equiv. | $89M | $229M | $781M | $98M | $325M |
BRBR vs HIMS vs TDOC vs SMPL vs NOMD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| BellRing Brands, In… (BRBR) | 100 | 51.3 | -48.7% |
| Hims & Hers Health,… (HIMS) | 100 | 284.6 | +184.6% |
| Teladoc Health, Inc. (TDOC) | 100 | 4.2 | -95.8% |
| The Simply Good Foo… (SMPL) | 100 | 72.0 | -28.0% |
| Nomad Foods Limited (NOMD) | 100 | 44.6 | -55.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRBR vs HIMS vs TDOC vs SMPL vs NOMD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRBR is the #2 pick in this set and the best alternative if efficiency is your priority.
- 8.0% ROA vs TDOC's -5.9%, ROIC 47.3% vs -11.5%
HIMS ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
- 188.5% 10Y total return vs NOMD's 31.8%
- 59.0% revenue growth vs NOMD's -2.2%
TDOC is the clearest fit if your priority is momentum.
- +2.4% vs BRBR's -83.3%
SMPL is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.34, Low D/E 16.8%, current ratio 3.64x
- Beta 0.34, current ratio 3.64x
- 6.3% margin vs TDOC's -6.8%
NOMD carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 2 yrs, beta 0.08, yield 7.6%
- Lower P/E (6.2x vs 7.4x)
- Beta 0.08 vs HIMS's 2.48, lower leverage
- 7.6% yield; 2-year raise streak; the other 4 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 59.0% revenue growth vs NOMD's -2.2% | |
| Value | Lower P/E (6.2x vs 7.4x) | |
| Quality / Margins | 6.3% margin vs TDOC's -6.8% | |
| Stability / Safety | Beta 0.08 vs HIMS's 2.48, lower leverage | |
| Dividends | 7.6% yield; 2-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +2.4% vs BRBR's -83.3% | |
| Efficiency (ROA) | 8.0% ROA vs TDOC's -5.9%, ROIC 47.3% vs -11.5% |
BRBR vs HIMS vs TDOC vs SMPL vs NOMD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
BRBR vs HIMS vs TDOC vs SMPL vs NOMD — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SMPL leads in 2 of 6 categories
NOMD leads 2 • HIMS leads 1 • BRBR leads 0 • TDOC leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SMPL leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NOMD is the larger business by revenue, generating $3.0B annually — 2.1x SMPL's $1.4B. SMPL is the more profitable business, keeping 6.3% of every revenue dollar as net income compared to TDOC's -6.8%. On growth, HIMS holds the edge at +28.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.3B | $2.3B | $2.5B | $1.4B | $3.0B |
| EBITDAEarnings before interest/tax | $289M | $164M | $42M | $231M | $429M |
| Net IncomeAfter-tax profit | $81M | $128M | -$171M | $91M | $133M |
| Free Cash FlowCash after capex | $192M | $73M | $251M | $174M | $227M |
| Gross MarginGross profit ÷ Revenue | +30.2% | +69.7% | +65.6% | +34.0% | +26.6% |
| Operating MarginEBIT ÷ Revenue | +12.6% | +4.6% | -7.6% | +14.4% | +10.6% |
| Net MarginNet income ÷ Revenue | +3.5% | +5.5% | -6.8% | +6.3% | +4.4% |
| FCF MarginFCF ÷ Revenue | +8.2% | +3.1% | +10.0% | +12.0% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.8% | +28.4% | -2.5% | -0.3% | -4.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -35.6% | -27.3% | +32.1% | -31.6% | 0.0% |
Valuation Metrics
NOMD leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 6.1x trailing earnings, BRBR trades at a 89% valuation discount to HIMS's 55.4x P/E. On an enterprise value basis, SMPL's 5.9x EV/EBITDA is more attractive than HIMS's 46.5x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.2B | $7.3B | $1.3B | $1.2B | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $2.2B | $8.2B | $1.6B | $1.4B | $3.6B |
| Trailing P/EPrice ÷ TTM EPS | 6.14x | 55.43x | -6.36x | 12.02x | 8.84x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.72x | 58.29x | — | 7.39x | 6.23x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.50x | — |
| EV / EBITDAEnterprise value multiple | 5.91x | 46.50x | 15.65x | 5.89x | 7.15x |
| Price / SalesMarket cap ÷ Revenue | 0.52x | 3.11x | 0.52x | 0.84x | 0.38x |
| Price / BookPrice ÷ Book value/share | — | 13.50x | 0.92x | 0.69x | 0.48x |
| Price / FCFMarket cap ÷ FCF | 4.68x | 98.70x | 4.58x | 7.74x | 4.53x |
Profitability & Efficiency
SMPL leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
HIMS delivers a 23.7% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-12 for TDOC. SMPL carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.07x. On the Piotroski fundamental quality scale (0–9), TDOC scores 6/9 vs NOMD's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +23.7% | -12.4% | +5.2% | +5.3% |
| ROA (TTM)Return on assets | +8.0% | +6.0% | -5.9% | +3.7% | +2.1% |
| ROICReturn on invested capital | +47.3% | +10.7% | -11.5% | +8.1% | +5.5% |
| ROCEReturn on capital employed | +55.3% | +10.9% | -10.0% | +9.4% | +6.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 6 | 5 | 4 |
| Debt / EquityFinancial leverage | — | 2.07x | 0.75x | 0.17x | 0.92x |
| Net DebtTotal debt minus cash | $1.0B | $892M | $259M | $206M | $2.0B |
| Cash & Equiv.Liquid assets | $89M | $229M | $781M | $98M | $325M |
| Total DebtShort + long-term debt | $1.1B | $1.1B | $1.0B | $304M | $2.3B |
| Interest CoverageEBIT ÷ Interest expense | 2.91x | — | -8.76x | 6.77x | 2.64x |
Total Returns (Dividends Reinvested)
HIMS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HIMS five years ago would be worth $27,393 today (with dividends reinvested), compared to $514 for TDOC. Over the past 12 months, TDOC leads with a +2.4% total return vs BRBR's -83.3%. The 3-year compound annual growth rate (CAGR) favors HIMS at 33.6% vs BRBR's -34.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -60.5% | -15.4% | +2.8% | -37.3% | -21.0% |
| 1-Year ReturnPast 12 months | -83.3% | -45.0% | +2.4% | -65.8% | -47.9% |
| 3-Year ReturnCumulative with dividends | -72.3% | +138.6% | -72.2% | -68.3% | -43.8% |
| 5-Year ReturnCumulative with dividends | -62.7% | +173.9% | -94.9% | -64.4% | -62.1% |
| 10-Year ReturnCumulative with dividends | -37.5% | +188.5% | -38.7% | +2.2% | +31.8% |
| CAGR (3Y)Annualised 3-year return | -34.8% | +33.6% | -34.7% | -31.8% | -17.5% |
Risk & Volatility
Evenly matched — TDOC and NOMD each lead in 1 of 2 comparable metrics.
Risk & Volatility
NOMD is the less volatile stock with a 0.08 beta — it tends to amplify market swings less than HIMS's 2.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TDOC currently trades 74.2% from its 52-week high vs BRBR's 15.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 2.48x | 1.89x | 0.34x | 0.08x |
| 52-Week HighHighest price in past year | $67.00 | $70.43 | $9.77 | $36.92 | $19.60 |
| 52-Week LowLowest price in past year | $9.21 | $13.74 | $4.40 | $10.21 | $9.17 |
| % of 52W HighCurrent price vs 52-week peak | +15.4% | +40.1% | +74.2% | +33.2% | +48.2% |
| RSI (14)Momentum oscillator 0–100 | 24.7 | 50.2 | 76.1 | 41.0 | 58.3 |
| Avg Volume (50D)Average daily shares traded | 3.6M | 34.8M | 5.2M | 2.8M | 1.4M |
Analyst Outlook
NOMD leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: BRBR as "Buy", HIMS as "Hold", TDOC as "Hold", SMPL as "Buy", NOMD as "Buy". Consensus price targets imply 157.5% upside for BRBR (target: $27) vs -7.3% for HIMS (target: $26). NOMD is the only dividend payer here at 7.56% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $26.55 | $26.20 | $7.58 | $18.33 | $13.50 |
| # AnalystsCovering analysts | 21 | 19 | 42 | 24 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +7.6% |
| Dividend StreakConsecutive years of raises | 0 | — | — | — | 2 |
| Dividend / ShareAnnual DPS | — | — | — | — | $0.61 |
| Buyback YieldShare repurchases ÷ mkt cap | +39.6% | +1.2% | 0.0% | +4.2% | +17.7% |
SMPL leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NOMD leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
BRBR vs HIMS vs TDOC vs SMPL vs NOMD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRBR or HIMS or TDOC or SMPL or NOMD a better buy right now?
For growth investors, Hims & Hers Health, Inc.
(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -2. 2% for Nomad Foods Limited (NOMD). BellRing Brands, Inc. (BRBR) offers the better valuation at 6. 1x trailing P/E (7. 7x forward), making it the more compelling value choice. Analysts rate BellRing Brands, Inc. (BRBR) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRBR or HIMS or TDOC or SMPL or NOMD?
On trailing P/E, BellRing Brands, Inc.
(BRBR) is the cheapest at 6. 1x versus Hims & Hers Health, Inc. at 55. 4x. On forward P/E, Nomad Foods Limited is actually cheaper at 6. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — BRBR or HIMS or TDOC or SMPL or NOMD?
Over the past 5 years, Hims & Hers Health, Inc.
(HIMS) delivered a total return of +173. 9%, compared to -94. 9% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: HIMS returned +188. 5% versus TDOC's -38. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRBR or HIMS or TDOC or SMPL or NOMD?
By beta (market sensitivity over 5 years), Nomad Foods Limited (NOMD) is the lower-risk stock at 0.
08β versus Hims & Hers Health, Inc. 's 2. 48β — meaning HIMS is approximately 3142% more volatile than NOMD relative to the S&P 500. On balance sheet safety, The Simply Good Foods Company (SMPL) carries a lower debt/equity ratio of 17% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BRBR or HIMS or TDOC or SMPL or NOMD?
By revenue growth (latest reported year), Hims & Hers Health, Inc.
(HIMS) is pulling ahead at 59. 0% versus -2. 2% for Nomad Foods Limited (NOMD). On earnings-per-share growth, the picture is similar: Teladoc Health, Inc. grew EPS 80. 6% year-over-year, compared to -35. 0% for Nomad Foods Limited. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRBR or HIMS or TDOC or SMPL or NOMD?
BellRing Brands, Inc.
(BRBR) is the more profitable company, earning 9. 3% net margin versus -7. 9% for Teladoc Health, Inc. — meaning it keeps 9. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BRBR leads at 15. 4% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRBR or HIMS or TDOC or SMPL or NOMD more undervalued right now?
On forward earnings alone, Nomad Foods Limited (NOMD) trades at 6.
2x forward P/E versus 58. 3x for Hims & Hers Health, Inc. — 52. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BRBR: 157. 5% to $26. 55.
08Which pays a better dividend — BRBR or HIMS or TDOC or SMPL or NOMD?
In this comparison, NOMD (7.
6% yield) pays a dividend. BRBR, HIMS, TDOC, SMPL do not pay a meaningful dividend and should not be held primarily for income.
09Is BRBR or HIMS or TDOC or SMPL or NOMD better for a retirement portfolio?
For long-horizon retirement investors, Nomad Foods Limited (NOMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
08), 7. 6% yield). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NOMD: +31. 8%, TDOC: -38. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRBR and HIMS and TDOC and SMPL and NOMD?
These companies operate in different sectors (BRBR (Consumer Defensive) and HIMS (Healthcare) and TDOC (Healthcare) and SMPL (Consumer Defensive) and NOMD (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BRBR is a small-cap high-growth stock; HIMS is a small-cap high-growth stock; TDOC is a small-cap quality compounder stock; SMPL is a small-cap deep-value stock; NOMD is a small-cap deep-value stock. NOMD pays a dividend while BRBR, HIMS, TDOC, SMPL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.